-
The Challenge
A European manufacturer was commissioning a new production facility that would produce primary products, by-products and complex substances, including Unknown or Variable Composition, Complex Reaction Products or Biological Materials (UVCBs).
To begin commercial production and supply the EU market, the client needed a complete set of EU REACH registrations in place from day one. The start-up timeline was fixed, leaving no room for delay
-
Our Role
ACRE provided end-to-end EU REACH regulatory support throughout the registration project. We advised on substance identification and analytical strategy, with a focus on complex substances and UVCBs. This helped the client avoid misclassification and unnecessary regulatory risk.
We prepared and submitted EU REACH inquiry dossiers, coordinated engagement with existing registrants and secured access to joint registrations through Letters of Access. We then prepared and submitted the required registration dossiers, including full registrations and registrations for intermediates under strictly controlled conditions. All work was delivered in line with regulatory requirements and the client’s production schedule.
-
The Outcome
The client moved from commissioning to full commercial production with all required EU REACH registrations in place. This enabled immediate access to EU markets and reduced regulatory risk at a critical stage of business growth. Complex substances were managed in line with EU REACH requirements, and the project strengthened the client’s internal capability to manage future regulatory obligations.
